Bajaj Healthcare Limited — Others, 14-11-2024: Statement of deviation(s) or variation(s) under Reg. 32

Bajaj Healthcare has confirmed that there is no deviation in the utilization of funds raised through its recent preferential issue of equity shares and convertible warrants, amounting to ₹204.97 crore. This statement was reviewed by the Audit Committee and indicates effective management of the funds. The company clarified that a portion allocated for general corporate purposes includes the repayment of an unsecured loan from its promoter, which has now been embedded within its broader corporate objectives. This clarity may enhance investor confidence, reflecting efficient governance and a positive outlook for future financial management.